Today is the final day of our discussion on this study. Thank you to all the study authors and experts who shared their perspectives and contributed to the discussion over the past 10 days! Your participation is sincerely appreciated.
In wrapping up, I would like to ask for your final thoughts on the study. What are your remaining questions? In the future, what role do you think prognostic and predictive biomarkers, like CDX2, will play in the management of colon cancer?